Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports. A number of ...
Citi lowered the firm’s price target on 10x Genomics (TXG) to $15 from $20 and keeps a Buy rating on the shares. The firm updated models in the ...
Xiaomi Redmi 10X 5G is officially announced in May 2020. The smartphone is fueled by a Non-removable Li-Po 4520 mAh battery + Fast charging 22.5W. The phone runs on the Android 10.0 + MIUI 11 ...
Genomics (TXG) provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, in ...
Genomics announced that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences.
Structural genomics projects aim to solve the experimental structures of all possible protein folds. Such projects entail a conceptual shift from traditional structural biology in which structural ...
With Spring Training underway, discussions about who will make Opening Day rosters are in full swing. While a majority of 26-man rosters are generally set, plenty of clubs will be evaluating battles ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology ...
Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly filed against Vizgen Inc. in 2022, alleging that Vizgen unlawfully used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results